Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
Open Access
- 31 July 2022
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 26, 343-354
Abstract
No abstract availableKeywords
Funding Information
- Infrastructures en Biologie Santé et Agronomie
- National Institutes of Health (DP1OD025535)
- College of Natural Resources and Sciences, Humboldt State University
- Aligarh Muslim University (IGS UMR7256)
This publication has 57 references indexed in Scilit:
- Improvements to Robotics-Inspired Conformational Sampling in RosettaPLOS ONE, 2013
- Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9Journal of Virology, 2012
- Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9Journal of Biological Chemistry, 2011
- New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0Systematic Biology, 2010
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- AAV9: a potential blood-brain barrier busterMolecular Therapy, 2009
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytesNature Biotechnology, 2008
- Phylogeny.fr: robust phylogenetic analysis for the non-specialistNucleic Acids Research, 2008
- WebLogo: A Sequence Logo Generator: Figure 1Genome Research, 2004
- MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research, 2004